These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 29772762

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.
    Messaoudi I, Vomaske J, Totonchy T, Kreklywich CN, Haberthur K, Springgay L, Brien JD, Diamond MS, Defilippis VR, Streblow DN.
    PLoS Negl Trop Dis; 2013; 7(7):e2343. PubMed ID: 23936572
    [Abstract] [Full Text] [Related]

  • 5. A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection.
    Teng TS, Kam YW, Lee B, Hapuarachchi HC, Wimal A, Ng LC, Ng LF.
    J Infect Dis; 2015 Jun 15; 211(12):1925-35. PubMed ID: 25635123
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response.
    Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzère BA, Bruniquet S, Jaffar Bandjee Z, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debré P, Autran B, Gasque P.
    J Immunol; 2010 May 15; 184(10):5914-27. PubMed ID: 20404278
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates.
    Rossi SL, Comer JE, Wang E, Azar SR, Lawrence WS, Plante JA, Ramsauer K, Schrauf S, Weaver SC.
    J Infect Dis; 2019 Jul 31; 220(5):735-742. PubMed ID: 31053842
    [Abstract] [Full Text] [Related]

  • 13. Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection.
    Reddy V, Mani RS, Desai A, Ravi V.
    J Med Virol; 2014 Aug 31; 86(8):1393-401. PubMed ID: 24523146
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Outbreak of chikungunya virus in a vulnerable population of Sergipe, Brazil-A molecular and serological survey.
    Cunha MDP, Santos CAD, Neto DFL, Schanoski AS, Pour SZ, Passos SD, Souza MSF, Costa DD, Zanotto PMA.
    J Clin Virol; 2017 Dec 31; 97():44-49. PubMed ID: 29100064
    [Abstract] [Full Text] [Related]

  • 19. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S, Nyo M, Phuektes P, Yew CW, Tan YJ, Chu JJ.
    MAbs; 2015 Dec 31; 7(6):1178-94. PubMed ID: 26305993
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.